Table 3.
Cohort N = 510 | n = 356 | MSAP n = 120 | SAP n = 34 | P values a | |
---|---|---|---|---|---|
Age years (mean ± SD) | 47.9 ± 11.9 | 47.7 ± 11.8 | 48.1 ± 12.2 | 48.7 ± 11.8 | 0.870 |
Male(%) | 319 (62.5%) | 225 (63.2%) | 75 (62.5%) | 19 (55.9%) | 0.701 |
Smoking | 128 (25.1%) | 82 (23.0%) | 38 (31.7%) | 8 (23.5%) | 0.267 |
Drinking | 87 (17.1%) | 60 (16.9%) | 24 (20.0%) | 3 (8.8%) | 0.185 |
BMI* | 25.5 ± 5.1 | 25.3 ± 5.0 | 25.8 ± 5.6 | 26.4 ± 3.8 | 0.449 |
Waist circumference | 87.0 ± 9.4 | 85.9 ± 9.1# | 89.1 ± 10.2 | 90.6 ± 8.1$ | 0.000 |
WTI | 221.7(10.7–3712.6) | 209.5(15.1–3712.6)# | 229.5(20.2-3507.0)& | 522.8(10.7-2804.0)$ | < 0.001 |
HTGW% | 185 (36.3%) | 113 (31.7%)# | 52 (43.3%) | 20 (58.8%) | 0.001 |
Etiology | 0.075 | ||||
Biliary | 144 (28.2%) | 108 (30.3%) | 28 (23.3%) | 8 (23.5%) | |
Alcohol | 34 (6.7%) | 26 (7.3%) | 7 (5.8%) | 1 (2.9%) | |
Hypertriglyceridemia | 205 (40.2%) | 136 (38.2%) | 48 (40.0%) | 21 (61.8%) | |
Others | 127 (24.9%) | 86 (24.2%) | 37 (30.8%) | 4 (11.4%) | |
WBC (109/L) | 11.9 ± 4.6 | 11.1 ± 4.1# | 13.6 ± 5.1 | 14.1 ± 5.2$ | 0.000 |
LDH (IU/L) | 195.7(4.4–1461.0) | 187.5(4.4–1461.0) | 222.0(110.0–786.0) | 313.0(139.0–1410.0) | 0.893 |
GLU (mmol/L) | 8.8 ± 4.0 | 8.3 ± 3.5# | 9.7 ± 4.3& | 11.6 ± 5.8$ | 0.000 |
BUN (mmol/L) | 4.8 ± 2.3 | 4.5 ± 1.9 | 5.2 ± 3.1 | 5.8 ± 2.0$ | 0.039 |
Cr (mmol/L) | 60.8(1.5–680) | 60.1(1.5–128.0)# | 63.3(17.0-181.0) | 69.5(30.0–680.0) | 0.017 |
TG (mmol/L) | 2.5(0.1–39.2) | 2.4(0.2–39.0) | 2.5(0.2–39.2)& | 6.0(0.1-29.4)$ | < 0.001 |
TC (mmol/L) | 4.4(1.1–17.1) | 4.4(1.1–17.1) | 4.4(2.1–12.2) | 4.5(1.7–10.9) | 0.679 |
All the shorthand are shown below: WBC white blood cells,LDH lactate dehydrogenase,GLU glucose,BUN blood urea nitrogen,Cr creatinine,and TG triglyceride
arepresents comparing among the three groups;
#represents the MAP compared with the MSAP group, P < 0.05
&represents the MSAP compared with the SAP group, P < 0.05
$represents the MAP compared with the SAP group, P < 0.05